3TC30mg+AZT60mg disp. tabs/PAC-60 No CTN

General Description
Lamivudine 30mg + Zidovudine 60mg dispersible tablets, in a bottle pack of 60 without outer carton. Tablets are used to prepare an oral suspension.

Technical Specifications
Each dispersible tablet contains Lamivudine 30mg and Zidovudine 60mg. Tablets are used to prepare an oral suspension. Tablets should be scored with at least one break line to allow for division of tablets into two parts, each containing the same amount of active ingredient.

Therapeutic class
Nucleoside Reverse Transcriptase Inhibitors (NRTI)

Dosage, Instructions for use:
Please refer to the guideline WHO Model Formulary 2008: https://www.who.int/selection_medicines/list/WMF2008.pdf
For more details, please see WHO treatment guidelines www.who.int/hiv/pub/guidelines/en/index.html and WHO Essential Medicines Library www.who.int/emlib/ or your regional/national guidelines.

Details about paediatric dosage schemes can be found at http://www.who.int/hiv/topics/paediatric/en/index.html

WHO generic tool for assessing paediatric ARV dosing
http://www.who.int/hiv/paediatric/generictool/en/

Shelf life:
36 months

Storage conditions:
Do not store above 30°C

Alternative products:
S1400649 - 3TC30mg+AZT60mg disp. tabs/PAC-60 gb